HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China flag China · Delayed Price · Currency is CNY
10.27
-0.44 (-4.11%)
Aug 20, 2026, 3:00 PM CST

SHA:600829 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
142.26133.84213.27292.16264.48277.3
Depreciation & Amortization
57.6357.4261.5460.1863.9960.44
Other Amortization
6.075.623.535.924.54.33
Loss (Gain) From Sale of Assets
0.490.44-0.230.350.36-0.07
Asset Writedown & Restructuring Costs
2.262.262.150.810.31.95
Loss (Gain) From Sale of Investments
---13.9-3.89--
Provision & Write-off of Bad Debts
48.4859.9719.2424.85-11.089.17
Other Operating Activities
24.4624.2228.2227.0227.0117.82
Change in Accounts Receivable
44.17163.19-10.6-228.880.7-292.96
Change in Inventory
-132.99-129.4716.45-41.4131.2217.35
Change in Accounts Payable
-171.11-1.15-204.15201.01-76.03-326.39
Operating Cash Flow
8.78299.98115.44332.99307.33-233
Operating Cash Flow Growth
-95.47%159.86%-65.33%8.35%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-27.74-17.16-8.04-23.48-6.42-12.24
Sale of Property, Plant & Equipment
0.160.130.150.260.550.69
Other Investing Activities
----156.64--
Investing Cash Flow
-27.58-17.02-7.89-179.86-5.87-11.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-790949.22681.731,3921,320
Total Debt Issued
822.4790949.22681.731,3921,320
Short-Term Debt Repaid
--840.6-1,072-917.8-1,299-699
Long-Term Debt Repaid
--42.5-42.19-46.42-42.75-44.93
Total Debt Repaid
-911.07-883.1-1,114-964.22-1,342-743.93
Net Debt Issued (Repaid)
-88.67-93.1-165.05-282.4950.12575.74
Common Dividends Paid
-18.76-20.08-160.41-24.62-30.48-35.65
Other Financing Activities
---424.97129.88-197.78
Financing Cash Flow
-107.43-113.18-325.46117.86149.51342.31

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-126.22169.78-217.92270.99450.9797.76

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-18.96282.82107.39309.5300.91-245.24
Free Cash Flow Growth
-163.34%-65.30%2.85%--
Free Cash Flow Margin
-0.18%2.73%1.07%2.98%3.12%-2.63%
Free Cash Flow Per Share
-0.030.490.180.530.52-0.42
Levered Free Cash Flow
-26.03347.5-16.7366.86406.36-152
Unlevered Free Cash Flow
-10.48362.810.98383.88434.13-120.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
288.82256.61305.32281.41254.71281.28
Change in Working Capital
-272.8716.2-198.39-74.41-42.23-603.92